Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

PATIENTS AND METHODS: Patients with metastatic solid tumors who had progressed on at least one line of standard of care therapy were referred to the Indiana University Health Precision Genomics Program. Tumor samples were submitted for DNA & RNA next-generation sequencing, fluorescence in situ h...

Descripción completa

Detalles Bibliográficos
Autores principales: Radovich, Milan, Kiel, Patrick J., Nance, Stacy M., Niland, Erin E., Parsley, Megan E., Ferguson, Meagan E., Jiang, Guanglong, Ammakkanavar, Natraj R., Einhorn, Lawrence H., Cheng, Liang, Nassiri, Mehdi, Davidson, Darrell D., Rushing, Daniel A., Loehrer, Patrick J., Pili, Roberto, Hanna, Nasser, Callaghan, J. Thomas, Skaar, Todd C., Helft, Paul R., Shahda, Safi, O’Neil, Bert H., Schneider, Bryan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302930/
https://www.ncbi.nlm.nih.gov/pubmed/27447854
http://dx.doi.org/10.18632/oncotarget.10606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302930/
https://www.ncbi.nlm.nih.gov/pubmed/27447854
http://dx.doi.org/10.18632/oncotarget.10606

Ejemplares similares